MDMA Pharmala Biotech Holdings Inc
- 0.125
- -0.010-7.41%
Pharmala Biotech Holdings Inc News
Red Light Holland Initiates Psilocybin Extraction Phase With PharmAla Following Successful Testing and Preparation by CCrest Labs
With the successful testing and preparation of our psilocybin truffles at CCrest Labs, we are now moving into an exciting phase of extraction with PharmAla.
Press Release: PharmAla Closes Private Placement and Concurrent Debt Settlement
PharmAla Closes Private Placement and Concurrent Debt Settlement VANCOUVER, British Columbia, April 19, 2024 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. ("PharmAla" or the "Company") (CSE: MDM
PharmAla Biotech Signs Sale Agreement With Numinus Wellness
PharmAla Biotech Holdings Inc. (MDMA.CN) had entered into a binding sales agreement with Numinus Wellness Inc. (NUMI.TO) to provide its GMP LaNeo MDMA for a prospective clinical trial. PharmAla also
PharmAla Biotech and Filament Health Announce Release of Second Batch of GMP MDMA Capsules
PharmAla Biotech Holdings Inc. (MDMA.CSE), a Canadian biotechnology company dedicated to the research and development of clinical-grade LaNeo MDMA and novel MDXX compounds, and Filament Health Corp.,
PharmAla Biotech Received First Office Action for PharmAla-1 PCT Filing
PharmAla Biotech Holdings Inc. (MDMA.CSE), a biotechnology company working on MDXX class molecules (including MDMA), on Monday announced that it has received the first office action from the Patent Co
PharmAla Biotech Filed Patent for Novel MDXX Molecule PharmAla-1
PharmAla Biotech Holdings Inc. (MDMA.CSE), a biotechnology company working on MDXX class molecules (including MDMA), on Monday said it has filed a patent on the composition of matter of PharmAla-1. Th
PharmAla Biotech Says Received Guidance on ALA-002 From MHRA; Launching Clinical Program With University of Sydney
PharmAla Biotech Holdings Inc. (MDMA.CSE), a biotechnology company working on MDXX class molecules (including MDMA), on Thursday said it has received written guidance from the UK's Medicines and Healt
The Power Play by The Market Herald Releases New Interviews With Pharmala Biotech Holdings, Nextech AR Solutions and Enertopia Discussing Their Latest News
VANCOUVER, BC / ACCESSWIRE / January 27, 2023 / The Power Play by The Market Herald has announced the release of new interviews with Pharmala Biotech Holdings, Nextech AR Solutions and Enertopia discu
Canadian Securities Exchange Reports January 2022 Performance Figures
Toronto, Ontario--(Newsfile Corp. - February 15, 2022) - The Canadian Securities Exchange ("CSE" or "the Exchange") today announced its market statistics for the month of January 2022, as well as cont
